Efficacy and tolerability profile of nebivolol vs atenolol in mild‐to‐moderate essential hypertension: Results of a double‐blind randomized multicentre trial-Reference-Cited by-同舟云学术

Efficacy and tolerability profile of nebivolol vs atenolol in mild‐to‐moderate essential hypertension: Results of a double‐blind randomized multicentre trial

Published:2003-01 Issue:sup2 Volume:12 Page:35-40
ISSN:0803-7051
Container-title:Blood Pressure
language:en
Short-container-title:Blood Pressure

Author:

Grassi Guido,Trevano Fosca Quarti,Facchini Annalisa,Toutouzas Torakis,Chanu Bernard,Mancia Giuseppe

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/08038020310023271

Reference19 articles.

1. Nebivolol in the Management of Essential Hypertension

2. PHARMACOLOGY OF NEBIVOLOL

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Nebivolol therapy on hemodynamic parameters and lipid profile compared to other beta blockers in patients with essential hypertension: a systematic review and meta-analysis;CASP J INTERN MED;2024

2. Modern ideas about the consequences of sympathoadrenal hyperactivation in hypertensive patients with metabolic disorders: modulation possibilities;Russian Journal of Cardiology;2023-12-19

3. Diabetogenic Effects of Antihypertensive Drugs and Statins;Blood Pressure Disorders in Diabetes Mellitus;2023

4. “A comparative study of Nebivolol plus Amlodipine and Atenolol plus Amlodipine on blood pressure and heart rate in patients of essential hypertensive patients”;Journal of Pharmaceutical Negative Results;2022-10-07

5. Efficacy and safety of nebivolol in hypertensive patients: a meta-analysis of randomized controlled trials;Journal of International Medical Research;2020-10